TABLE 2.

Brainstem auditory-evoked responses at 1 and 3 mo among singleton children whose mothers participated in a supplementation trial of 400 mg/d DHA vs. placebo during the second half of pregnancy, by treatment allocation¹

	Placebo	DHA	P2
One mo	n = 377	n = 372
Age at measurement, d	34.5 ± 5.5	34.2 ± 5.1	0.47
Latency 1, ms	1.63 ± 0.14	1.62 ± 0.16	0.36
Latency 3, ms	4.19 ± 0.33	4.18 ± 0.32	0.65
Latency 5, ms	6.55 ± 0.42	6.52 ± 0.48	0.35
Interpeak latency 1–3, ms	2.57 ± 0.36	2.56 ± 0.27	0.56
Interpeak latency 3–5, ms	2.37 ± 0.30	2.37 ± 0.34	0.89
Interpeak latency 1–5, ms	4.93 ± 0.36	4.91 ± 0.39	0.60
Three mo	n = 334	n = 330
Age at measurement, d	94.2 ± 5.6	94.6 ± 5.5	0.41
Latency 1, ms	1.58 ± 0.15	1.58 ± 0.15	0.87
Latency 3, ms	4.02 ± 0.32	4.03 ± 0.33	0.59
Latency 5, ms	6.33 ± 0.40	6.29 ± 0.42	0.24
Interpeak latency 1–3, ms	2.44 ± 0.28	2.45 ± 0.28	0.66
Interpeak latency 3–5, ms	2.31 ± 0.35	2.28 ± 0.33	0.23
Interpeak latency 1–5, ms	4.75 ± 0.39	4.72 ± 0.39	0.34

¹Data are mean ± SD. Sample includes all infants measured at that age.

²Significance of difference in means between treatment groups, by test.